BBC3 and cancer: The wild-type p53-PUMA pathway was found to have the potential to drive the metabolic switch of cancer cells, and wild-type p53 is required for the maintenance of cancer cell growth and glycolysis in several cancers [93], indicating that activation of p53 in some cases may have the opposite effect, which was consistent with results from other studies [94–96].